Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hemophilia Alliance GPO is a specialized group purchasing organization that serves Hemophilia Treatment Centers (HTCs) across the United States. It negotiates competitive contracts and pricing for clotting factor concentrates and other essential therapies used in the treatment of bleeding disorders. By aggregating the purchasing power of its member centers, the GPO ensures that HTCs can maintain the financial stability necessary to provide comprehensive care. Beyond procurement, the organization offers advocacy, legal expertise, and operational support to help its members navigate the complex healthcare reimbursement landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemophilia Alliance GPO.